2,3-Dihydroxypropyl oleate is a lipid of Glycerolipids (GL) class. The involved functions are known as enzyme activity and acyltransferase activity. 2,3-dihydroxypropyl oleate often locates in soluble fraction.
To understand associated biological information of 2,3-Dihydroxypropyl oleate, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
There are no associated biomedical information in the current reference collection.
We collected disease MeSH terms mapped to the references associated with 2,3-Dihydroxypropyl oleate
| MeSH term | MeSH ID | Detail |
|---|---|---|
| Burns | D002056 | 34 associated lipids |
| Body Weight | D001835 | 333 associated lipids |
| Edema | D004487 | 152 associated lipids |
| Arthritis | D001168 | 41 associated lipids |
| Abscess | D000038 | 13 associated lipids |
| Psoriasis | D011565 | 47 associated lipids |
| Hypertension, Renovascular | D006978 | 10 associated lipids |
| Blood Loss, Surgical | D016063 | 6 associated lipids |
There are no associated biomedical information in the current reference collection.
Associated locations are in red color. Not associated locations are in black.
| Location | Cross reference | Weighted score | Related literatures |
|---|
| Function | Cross reference | Weighted score | Related literatures |
|---|
There are no associated biomedical information in the current reference collection.
There are no associated biomedical information in the current reference collection.
There are no associated biomedical information in the current reference collection.
| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Nithipatikom K et al. | 2-arachidonoylglycerol: a novel inhibitor of androgen-independent prostate cancer cell invasion. | 2004 | Cancer Res. | pmid:15604240 |
| Kraineva J et al. | Kinetics of lamellar-to-cubic and intercubic phase transitions of pure and cytochrome c containing monoolein dispersions monitored by time-resolved small-angle X-ray diffraction. | 2005 | Langmuir | pmid:15807602 |
| Shah MH and Paradkar A | Cubic liquid crystalline glyceryl monooleate matrices for oral delivery of enzyme. | 2005 | Int J Pharm | pmid:15814241 |
| Bilewicz R et al. | Modified electrodes based on lipidic cubic phases. | 2005 | Bioelectrochemistry | pmid:15833697 |
| Lopes LB et al. | Topical delivery of cyclosporin A: an in vitro study using monoolein as a penetration enhancer. | 2005 | Eur J Pharm Biopharm | pmid:15848052 |
| Johnsson M et al. | Aqueous phase behavior and dispersed nanoparticles of diglycerol monooleate/glycerol dioleate mixtures. | 2005 | Langmuir | pmid:15896065 |
| Amar-Yuli I and Garti N | Transitions induced by solubilized fat into reverse hexagonal mesophases. | 2005 | Colloids Surf B Biointerfaces | pmid:15921902 |
| Masum SM et al. | Effect of positively charged short peptides on stability of cubic phases of monoolein/dioleoylphosphatidic acid mixtures. | 2005 | Langmuir | pmid:15924452 |
| Wang Z et al. | Effect of sucrose on the structure of a cubic phase formed from a monoolein/water mixture. | 2005 | J Colloid Interface Sci | pmid:15927636 |
| Bender J et al. | Lipid cubic phases for improved topical drug delivery in photodynamic therapy. | 2005 | J Control Release | pmid:15967535 |